AHK-Cu is best understood as the hair-focused cousin of GHK-Cu. Both are tiny "copper peptides" — three amino acids wrapped around a copper ion — from the same family of skin- and repair-signalling molecules. GHK-Cu built its reputation on skin: collagen, wound healing, anti-ageing. AHK-Cu is the one cosmetic chemists reach for when the target is the hair follicle.
In plain terms: same copper-peptide idea, aimed at your scalp instead of your skin.
What it is
AHK-Cu is a copper-binding tripeptide made of three amino acids — alanine, histidine, and lysine (A-H-K) — complexed with a copper (Cu²⁺) ion1. Copper peptides like this occur naturally in the body and bind copper with high affinity, which is central to how they signal2. The only chemical difference between AHK-Cu and GHK-Cu is the first amino acid — glycine in GHK, alanine in AHK — but that small change shifts what the molecule is used for.
AHK-Cu vs GHK-Cu — the difference people ask about
This is the question most people arrive with, so here it is plainly:
- GHK-Cu (glycine-histidine-lysine-copper) is the heavily studied one, tied to skin: collagen production, wound healing, blood-vessel growth, and anti-inflammatory remodeling23.
- AHK-Cu (alanine-histidine-lysine-copper) is positioned for hair, based on lab work showing it acts on the cells at the base of the hair follicle1.
They are not rivals so much as siblings with different day jobs — and in hair products the two are sometimes combined. The important caveat: GHK-Cu has by far the larger evidence base, and much of what gets said about "copper peptides for hair" actually rests on GHK-Cu or general copper-peptide biology, not on AHK-Cu specifically.
How it is thought to work (on hair)
The base of every hair follicle contains dermal papilla cells — specialised cells that act as the follicle's control room, setting how much it grows. In a 2007 study, AHK-Cu stimulated the proliferation of human dermal papilla cells and lengthened human hair follicles grown outside the body (ex vivo)1.
Two signals seemed to matter. AHK-Cu raised vascular endothelial growth factor (VEGF), which supports the tiny blood vessels that feed a follicle, and lowered transforming growth factor-β1 (TGF-β1), a signal linked to pushing follicles into their resting, shedding phase1. More blood supply and less "time to rest" is, in theory, a follicle-friendly combination.
In plain terms: in the lab it nudged hair-follicle cells to grow and fed them better — but that was in a dish and in isolated follicles, not on people's heads.
What the studies actually found
AHK-Cu's direct evidence is small and mostly preclinical. Note the model.
| Study | Model | Key result | Year |
|---|---|---|---|
| Pyo et al.1 | human dermal papilla cells + hair follicles (in vitro / ex vivo) | AHK-Cu stimulated dermal papilla cell proliferation and follicle elongation; raised VEGF, lowered TGF-β1 | 2007 |
| Pickart et al. — reviews (GHK family)23 | reviews of copper-peptide biology | How copper tripeptides bind copper and drive skin-repair signalling — the mechanistic backdrop AHK-Cu shares | 2015–2018 |
The honest summary: the direct AHK-Cu hair data is essentially one line of laboratory work, backed by the broader (and much stronger) copper-peptide biology built around GHK-Cu. In practice AHK-Cu shows up in topical scalp serums and injectable "mesotherapy" hair cocktails, often alongside GHK-Cu and growth factors — cosmetic uses described here for context, not as a recommendation.
Honest limits
- No robust human hair-loss trials. The follicle results are from cells and isolated follicles, not controlled studies in people — a long way from proof that it regrows hair on a scalp.
- It is a cosmetic ingredient, not an approved drug. Unlike minoxidil or finasteride, which have large human trials and regulatory approval for hair loss, AHK-Cu is used cosmetically without that evidence base.
- Most "copper peptide" evidence is really GHK-Cu's. When you read strong claims about copper peptides for hair, check whether the study was actually on AHK-Cu or on its better-studied cousin.
Regulatory status
AHK-Cu is a cosmetic ingredient, not an approved medicine for hair loss or anything else. This page explains what it is and what the lab studies showed — not how to use it — and it takes no position on sourcing.
The short version
AHK-Cu is a copper tripeptide (alanine-histidine-lysine + copper), the hair-focused cousin of the skin peptide GHK-Cu. Lab and ex-vivo studies show it can stimulate the dermal papilla cells that drive hair follicles — raising VEGF and lowering TGF-β1 — but the direct human evidence is thin, and it is a cosmetic ingredient rather than an approved hair-loss treatment. Promising biology, early evidence. Educational overview only, not medical advice.